• Home
  • Study Materials
    • BCPS Study Material Options
    • BCGP Study Material Options
    • BCACP Study Material Options
    • BCMTMS Study Material Options
    • NAPLEX Study Material
  • Resources
    • Amazon Books
    • Audiobooks
    • Professional Development
    • Free Stuff
  • Blog
  • Podcast
  • Contact
  • My Account
Ranking NSAIDs According To GI Risk

Ranking NSAIDs According To GI Risk

by Eric Christianson | Apr 20, 2022 | Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls

Throughout my career, I have had various clinicians develop trends in the NSAID that they prefer to use. Why do we choose ibuprofen versus diclofenac versus piroxicam? In this post, I will be ranking NSAIDs according to their GI risk based upon the literature we have....
Acetaminophen in Osteoarthritis

Acetaminophen in Osteoarthritis

by Eric Christianson | Nov 14, 2021 | Medication and Disease State Clinical Pearls For Pharmacists

When I was in school, acetaminophen was considered the go agent for the management of osteoarthritis pain. While acetaminophen in osteoarthritis is still possibly a 2nd or 3rd line consideration, more evidence has come to light over the years that maybe it really...
Glucosamine and Chondroitin For Arthritis: To Use It Or Not?

Glucosamine and Chondroitin For Arthritis: To Use It Or Not?

by Eric Christianson | Oct 3, 2021 | Medication and Disease State Clinical Pearls For Pharmacists

Patients will frequently ask me what supplements they should use to help treat their conditions and more often, they begin to take something even prior to asking. I was recently asked my thoughts on glucosamine and chondroitin for arthritis, and more specifically,...
Avoid NSAIDs in COVID-19? Where’s the Evidence?

Avoid NSAIDs in COVID-19? Where’s the Evidence?

by Eric Christianson | Mar 18, 2020 | Clinical Pharmacy News and New Drug Updates

I’m seeing this article all over the place recommending to avoid NSAIDs in patients who have an infection with the new COVID-19 coronavirus. My question is, where’s the evidence? The only thing I can find is that it was based upon is a scientific theory as...
Strategies to Reduce GI Risk With NSAIDs

Strategies to Reduce GI Risk With NSAIDs

by Eric Christianson | Oct 2, 2019 | Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls

A 68-year-old male presents to your care with chronic back pain. He is taking ketorolac and states that NSAIDs are the mainstay of pain relief. He won’t take opioids due to a family history of addiction. Acetaminophen and other medications he has tried in the...
« Older Entries
Next Entries »

Study Materials For Pharmacists

Free 18 Page PDF On The Most Notable Drug Interactions!

CLICK HERE, subscribe now, and get a free PDF on my TOP Drug Interactions in clinical practice!

Looking for something?

Recent Posts

  • Acyclovir Versus Valacyclovir – What’s the Difference?
  • Prescribing Cascade in Dementia Care – My Top 5
  • Comparing Azole Adverse Effects
  • Recommendations in Long Term Care – 5 Recent Examples
  • Prednisone Clinical Pearls – My Top 5

Categories

Subscribe to the Blog

Enjoy the blog? Over 6,000 pharmacy loving folks follow the blog, why aren’t you? Subscribe now and get a free gift as well!

Success!

Subscribe

NAVIGATION

  • Home
  • Contact
  • About
  • Terms of Service
  • Privacy Policy

Subscribe to the Blog!

Enjoy the blog?  Over 6,000 pharmacy loving folks follow the blog, why aren't you? Subscribe now and get a free gift as well!

Recent Posts

  • Acyclovir Versus Valacyclovir – What’s the Difference?
  • Prescribing Cascade in Dementia Care – My Top 5
  • Comparing Azole Adverse Effects
  • Recommendations in Long Term Care – 5 Recent Examples
  • Prednisone Clinical Pearls – My Top 5

Copyright 2024 –  MEDED101.COM